×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
PD09-3: The incidence and multiplex nomogram for prediction of metachronous and synchronous upper tract urothelial cancer in patients with non-muscle invasive urinary bladder cancer
2023-07-05
PD09-4: Impact of erythropoiesis-stimulating agents on patients with end stage renal disease and early-stage urothelial carcinoma: A real-world study
2023-07-05
PD09-5: The Effects of Cyproheptadine in Eliciting Natural Killer cell-mediated Immune Response in Bladder Cancer
2023-07-05
PD09-6: Down-regulation of Aquaporins Sensitizes Atezolizumab-induced Cytotoxicity of urothelial carcinoma
2023-07-05
PD09-2: Is the native upper urinary tract urothelial carcinoma different between dialysis patients and renal transplant recipients?
2023-07-05
PD09-1: Recruitment of lymphatic endothelial cells by thrombospondin-4 induces lymphangiogenesis in human bladder tumors
2023-07-05
PD02-6: Comparison of the adverse events between 2 different BCG strains in patients receiving intravesical therapy for non-muscle invasive bladder urothelial carcinoma: A single center experience
2023-07-05
PD02-5: The farnesoid X receptor agonist GW4064 inhibits migration and invasion through β-catenin and MMP2 downregulation in human bladder cancer
2023-07-05
PD02-4: The prognostic significance of CEBPD expression in patients with bladder urothelial carcinoma
2023-07-05
PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
2023-07-05
PD02-2: GDF15/prothymosin α signaling disruption as a potential therapy for muscle wasting in bladder cancer patients treated with cisplatin
2023-07-05
PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
2023-07-05
PD01-6: Analyzing the effects of testosterone level on nocturia in prostate cancer patients receiving androgen deprivation therapy
2023-07-05
PD01-5: The efficacy of behavioral therapy and different dosage of β3-adrenoceptor agonist treatment for male overactive bladder patients, a comparison study
2023-07-05
PD01-4: Normal post void residual urine in healthy adults
2023-07-05
PD01-3: Complication Analysis of Transurethral Resection of Prostate Under Different Types of Anesthesia: A Nationwide, Population-based Cohort Study
2023-07-05
PD01-2: Low Intensity Extracorporeal Shockwave Targeting at Dorsal Root Ganglion Attenuate Nociceptive Markers and BOLD activity in a Rat Model of Nonbacterial Chronic Prostatitis
2023-07-05
PD01-1: The diagnostic rule of prostatic urethral angle in diagnosis of bladder neck dysfunction in men with lower urinary tract symptoms and small prostate volume
2023-07-05
NPD84: Retrograde intrarenal surgery for a complete renal staghorn stone: a case report
2023-07-05
NPD83: Pediatric spina bifida combined with neurogenic bladder: A case report
2023-07-05
NPD82: Non-negligible complication during transurethral resection of the prostate, hyperchloremic metabolic acidosis: a case report and review of literature
2023-07-05
NPD81: Spontaneous renal pelvis rupture caused by distal ureteral stone
2023-07-05
NPD80: Testicular Abscess - An Extrapulmonary Manifestation of Tuberculosis
2023-07-05
NPD79: Large bladder stones with concurrent urethral steinstrasse: A rare case report
2023-07-05
<
17
18
19
20
21
22
23
24
25
26
>
/ 127